-transparent.png){kind=logo}
The use of recombinant human erythropoietin (r-HuEPO) corrects the anemia of chronic hemodialysis (HD) patients and improves their quality of life. The role of r-HuEPO in the genesis of graft thrombosis is controversial. A retrospective study was conducted of 46 stable chronic HD patients receiving r-HuEPO. It showed an increase in graft thrombosis in those who received the drug.
Related Publications
G R Dy, and
E J Bloom, and
G K Ijelu, and
G W Merritts, and
M S Kramer, and
R M Raja
January 1992,
ASAIO journal (American Society for Artificial Internal Organs : 1992),
G R Dy, and
E J Bloom, and
G K Ijelu, and
G W Merritts, and
M S Kramer, and
R M Raja
June 1994,
JAMA,
G R Dy, and
E J Bloom, and
G K Ijelu, and
G W Merritts, and
M S Kramer, and
R M Raja
April 1994,
Journal of the American Society of Nephrology : JASN,
G R Dy, and
E J Bloom, and
G K Ijelu, and
G W Merritts, and
M S Kramer, and
R M Raja
February 1999,
Kidney international,
G R Dy, and
E J Bloom, and
G K Ijelu, and
G W Merritts, and
M S Kramer, and
R M Raja
March 1991,
Clinical and experimental immunology,
G R Dy, and
E J Bloom, and
G K Ijelu, and
G W Merritts, and
M S Kramer, and
R M Raja
March 1995,
Clinical nephrology,
G R Dy, and
E J Bloom, and
G K Ijelu, and
G W Merritts, and
M S Kramer, and
R M Raja
August 1990,
British journal of haematology,
G R Dy, and
E J Bloom, and
G K Ijelu, and
G W Merritts, and
M S Kramer, and
R M Raja
January 1990,
Kidney international,
G R Dy, and
E J Bloom, and
G K Ijelu, and
G W Merritts, and
M S Kramer, and
R M Raja
January 1991,
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
G R Dy, and
E J Bloom, and
G K Ijelu, and
G W Merritts, and
M S Kramer, and
R M Raja
January 1991,
Contributions to nephrology,
